Loading...

Sanofi

SNW.DEXETRA
HealthcareDrug Manufacturers - General
88.43
0.95(1.09%)

Sanofi (SNW.DE) Financial Performance & Statements

Review Sanofi’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.

Revenue Growth
-3.80%
3.80%
Operating Income Growth
-7.91%
7.91%
Net Income Growth
2.96%
2.96%
Operating Cash Flow Growth
-11.47%
11.47%
Operating Margin
18.55%
18.55%
Gross Margin
71.13%
71.13%
Net Profit Margin
14.39%
14.39%
ROE
8.48%
8.48%
ROIC
8.15%
8.15%

Sanofi (SNW.DE) Financial Statements

Explore quarterly and annual reports including balance sheet, income statement, cash flow for Sanofi stock.

MetricQ4 2024Q3 2024Q2 2024Q1 2024
Revenue$7.63B$14.16B$11.38B$11.12B
Cost of Revenue$2.27B$4.08B$3.39B$3.44B
Gross Profit$5.36B$10.07B$7.99B$7.68B
Gross Profit Ratio$0.70$0.71$0.70$0.69
R&D Expenses$2.12B$1.85B$1.72B$1.72B
SG&A Expenses$1.24B$2.68B$2.69B$2.60B
Operating Expenses$4.79B$6.44B$6.63B$6.27B
Total Costs & Expenses$7.06B$10.52B$10.02B$9.71B
Interest Income$0.00$133.00M$56.00M$102.00M
Interest Expense$0.00$265.00M$135.00M$253.00M
Depreciation & Amortization$209.00M$479.00M$882.00M$829.50M
EBITDA$563.00M$4.25B$2.51B$2.86B
EBITDA Ratio$0.07$0.30$0.22$0.26
Operating Income$573.00M$3.63B$1.63B$2.03B
Operating Income Ratio$0.08$0.26$0.14$0.18
Other Income/Expenses (Net)-$117.00M-$132.00M-$179.00M-$139.00M
Income Before Tax$456.00M$3.50B$1.42B$1.31B
Income Before Tax Ratio$0.06$0.25$0.12$0.12
Income Tax Expense$4.00M$737.00M$299.00M$164.00M
Net Income$499.00M$2.81B$1.11B$1.13B
Net Income Ratio$0.07$0.20$0.10$0.10
EPS$0.40$2.25$0.89$0.91
Diluted EPS$0.40$2.25$0.88$0.91
Weighted Avg Shares Outstanding$986.42M$1.25B$1.25B$1.25B
Weighted Avg Shares Outstanding (Diluted)$1.26B$1.25B$1.25B$1.25B

Unlock 25+ Years of Financial Data

Get access to extended historical data, advanced metrics, and more with our premium plan

Frequently Asked Questions